CG100649,
polmacoxib,
Polmacoxib,
301692-76-2,
UNII-IJ34D6YPAO,
CG100649,
IJ34D6YPAO,
4-(3-(3-fluorophenyl)-5,5-dimethyl-4-oxo-4,5-dihydrofuran-2-yl)benzenesulfonamide,
4-(3-(3-Fluorophenyl)-5,5-dimethyl-4-oxo-4,5-dihydrofuran-2-yl)-benzenesulfonamide,
4-[3-(3-Fluorophenyl)-5,5-Dimethyl-4-Oxidanylidene-Furan-2-Yl]benzenesulfonamide,
Polmacoxib [USAN:INN],
CG-100649,
Acelex (S. Korea),
CG 100649,
Polmacoxib (USAN/INN),
CHEMBL166863,
GTPL8316,
SCHEMBL3233093,
EX-A601,
IJWPAFMIFNSIGD-UHFFFAOYSA-N,
ZINC589683,
BCP15550,
AKOS025149767,
DB12399,
SB17177,
DA-42861,
FT-0700281,
D10656,
J-690277,
4-[3-(3-fluorophenyl)-5,5-dimethyl-4-oxofuran-2-yl]benzenesulfonamide,
2-(4-tert-Butylphenyl)-1H-benzimidazole, 2-[4-(1,1-Dimethylethyl)phenyl]-1H-benzimidazole,
5-{4-(aminosulfonyl)phenyl}-2,2-dimethyl-4-(3-fluorophenyl)-3(2H)-furanone,
Benzenesulfonamide, 4-(3-(3-fluorophenyl)-4,5-dihydro-5,5-dimethyl-4-oxo-2-furanyl)-,
acelex,
D0W2CX,
CID9841854,
4-[3-(3-fluorophenyl)-5,5-dimethyl-4-oxo-2-furyl]benzenesulfonamide,